Yoko Katsura
Overview
Explore the profile of Yoko Katsura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harada S, Harada N, Sasano H, Tanabe Y, Kotajima M, Sato Y, et al.
PLoS One
. 2024 Sep;
19(9):e0309981.
PMID: 39240983
Background: Oscillometry devices (also termed forced oscillation technique) devices such as MasterScreen-IOS® (Jaeger, Hochberg, Germany) and MostGraph-01® (Chest, Tokyo, Japan) are useful for obtaining physiological assessments in patients with obstructive...
2.
Sandhu Y, Harada N, Harada S, Nishimaki T, Sasano H, Tanabe Y, et al.
Curr Issues Mol Biol
. 2023 Nov;
45(11):8907-8924.
PMID: 37998736
The mitogen-activated protein kinase (MAPK) signaling pathway is involved in the epithelial-mesenchymal transition (EMT) and asthma; however, the role of mitogen-activated protein kinase kinase kinase 19 (MAP3K19) remains uncertain. Therefore,...
3.
Abe S, Ito J, Harada S, Sasano H, Ueda S, Sandhu Y, et al.
Allergy Asthma Clin Immunol
. 2021 Apr;
17(1):36.
PMID: 33789748
Background: Although Japanese radish (Raphanus sativus L.) is a common Japanese ingredient, there are few reports of IgE-mediated immediate food allergy caused by Japanese radish. Case Presentation: A 48-year-old woman...
4.
Takeshige T, Harada N, Harada S, Ishimori A, Katsura Y, Sasano H, et al.
Allergol Int
. 2021 Feb;
70(3):343-350.
PMID: 33640239
Background: Previous reports have shown that pathogen-associated patterns (PAMPs) induce the production of interleukin (IL)-1β in macrophages. Moreover, studies using mouse models also suggest that chitin, which acts as a...
5.
Matsuno K, Harada N, Harada S, Takeshige T, Ishimori A, Itoigawa Y, et al.
Exp Lung Res
. 2019 Jan;
44(7):332-343.
PMID: 30676129
Aim Of The Study: In patients with asthma, chronic inflammatory processes and the subsequent remodeling of the airways contribute to the symptoms and the pathophysiological changes. Epithelial-mesenchymal transition (EMT) is...
6.
Yasuda M, Harada N, Harada S, Ishimori A, Katsura Y, Itoigawa Y, et al.
Allergy Asthma Clin Immunol
. 2018 Nov;
14:72.
PMID: 30473714
Background: Extracellular matrix proteins tenascin-C (TNC) and periostin, which were identified as T-helper cell type 2 cytokine-induced genes in human bronchial epithelial cells, accumulate in the airway basement membrane of...
7.
Tanabe Y, Harada N, Ito J, Matsuno K, Takeshige T, Harada S, et al.
J Asthma
. 2018 Oct;
56(2):167-172.
PMID: 30335533
Background: Fractional exhaled nitric oxide (FE) is useful for the evaluation of eosinophilic airway inflammation, including that seen in asthma. Although a new electrochemical hand-held FE analyzer, the NIOX VERO...
8.
Sasaki S, Yoshioka Y, Ko R, Katsura Y, Namba Y, Shukuya T, et al.
Respir Investig
. 2016 Jan;
54(1):14-9.
PMID: 26718140
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been successfully used to treat patients with non-small cell lung cancer (NSCLC) harboring EGFR mutations. However, despite an initial...
9.
Harada S, Harada N, Itoigawa Y, Katsura Y, Kasuga F, Ishimori A, et al.
J Asthma
. 2015 Sep;
53(2):207-12.
PMID: 26325232
Objective: Treatment guidelines for asthma recommend step-down therapy for well-controlled asthma patients. However, the precise strategy for step-down therapy has not been well defined. We investigated whether well-controlled patients with...
10.
Katsura Y, Harada N, Harada S, Ishimori A, Makino F, Ito J, et al.
Exp Lung Res
. 2015 Jul;
41(7):370-82.
PMID: 26151756
Background: Macrophages include the classically activated pro-inflammatory M1 macrophages (M1s) and alternatively activated anti-inflammatory M2 macrophages (M2s). The M1s are activated by both interferon-γ and Toll-like receptor ligands, including lipopolysaccharide...